JP Morgan Chase’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
DAM
F
JP Morgan Chase's NVO Position: Q1 2026 in Review
JP Morgan Chase reduced its Novo Nordisk (NVO) stake by 21% in Q1 2026, selling an estimated $34.3M and leaving 2,808,818 shares worth $99.1M. The position accounts for 0.01% of the portfolio, ranked #989.
JP Morgan Chase first reported a position in NVO in Q2 2013 and has held it in 52 quarters since. The position peaked at $722M in Q1 2024. 1,273 funds tracked by Wall St. Rank hold NVO as of Q1 2026.
- JP Morgan Chase held 2,808,818 shares of Novo Nordisk worth $99.1M as of Q1 2026.
- JP Morgan Chase sold 724,819 Novo Nordisk shares in Q1 2026, an estimated $34.3M.
- Novo Nordisk made up 0.01% of JP Morgan Chase's portfolio in Q1 2026, its #989 holding.
- JP Morgan Chase first reported a position in Novo Nordisk in Q2 2013 and has held it in 52 quarters since.
- JP Morgan Chase's Novo Nordisk position peaked at $722M in Q1 2024.
- 1,273 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.
Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.